155 related articles for article (PubMed ID: 34261754)
1. Proton pump inhibitors and gastric cancer: a population-based cohort study.
Patel J; Berezowski I; Janapala RN; Pourmand A
Gut; 2022 May; 71(5):1039-1041. PubMed ID: 34261754
[No Abstract] [Full Text] [Related]
2. OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer.
Arai J; Niikura R; Hayakawa Y; Aoki T; Yamada A; Kawai T; Fujishiro M
Gut; 2022 May; 71(5):1043-1044. PubMed ID: 34344784
[No Abstract] [Full Text] [Related]
3. Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for
Niikura R; Hayakawa Y; Hirata Y; Yamada A; Fujishiro M; Koike K
Gut; 2018 Oct; 67(10):1908-1910. PubMed ID: 29273641
[No Abstract] [Full Text] [Related]
4. Haemorrhagic gastric hyperplastic polyps associated with long-term use of proton pump inhibitor in a case without Helicobacter pylori infection.
Kinoshita S; Nishizawa T; Mori H; Kikuchi M
J Clin Pharm Ther; 2019 Jun; 44(3):493. PubMed ID: 30773665
[No Abstract] [Full Text] [Related]
5. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.
Parsons BN; Ijaz UZ; D'Amore R; Burkitt MD; Eccles R; Lenzi L; Duckworth CA; Moore AR; Tiszlavicz L; Varro A; Hall N; Pritchard DM
PLoS Pathog; 2017 Nov; 13(11):e1006653. PubMed ID: 29095917
[TBL] [Abstract][Full Text] [Related]
6. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for
Cheung KS; Chan EW; Wong AYS; Chen L; Wong ICK; Leung WK
Gut; 2018 Jan; 67(1):28-35. PubMed ID: 29089382
[TBL] [Abstract][Full Text] [Related]
7.
Suzuki H; Matsuzaki J
Gut; 2018 Nov; 67(11):2071-2072. PubMed ID: 29247066
[No Abstract] [Full Text] [Related]
8. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.
Sanduleanu S; Jonkers D; De Bruine A; Hameeteman W; Stockbrügger RW
Aliment Pharmacol Ther; 2001 Mar; 15(3):379-88. PubMed ID: 11207513
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.
Kim N
J Gastroenterol Hepatol; 2019 Aug; 34(8):1287-1295. PubMed ID: 30828872
[TBL] [Abstract][Full Text] [Related]
10. Long-term proton pump inhibitor use after
Kobayashi J; Uchida H; Ito J
Gut; 2019 Jun; 68(6):1131. PubMed ID: 29802173
[No Abstract] [Full Text] [Related]
11. Long-term proton pump inhibitor use and gastrointestinal cancer.
Graham DY; Genta RM
Curr Gastroenterol Rep; 2008 Dec; 10(6):543-7. PubMed ID: 19006608
[TBL] [Abstract][Full Text] [Related]
12. Can We StoP Worrying about Long-term PPIs and Gastric Cancer Risk?
Richman CM; Leiman DA
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1127-1129. PubMed ID: 37655427
[TBL] [Abstract][Full Text] [Related]
13. Editorial: PPIs and gastric cancer-Are we dealing with a carcinogen?
Malfertheiner P; Schulz C; Howden CW
Aliment Pharmacol Ther; 2023 Nov; 58(10):1099-1100. PubMed ID: 37885170
[No Abstract] [Full Text] [Related]
14. Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease.
Vakil N
Gastroenterol Clin North Am; 2015 Sep; 44(3):661-6. PubMed ID: 26314675
[TBL] [Abstract][Full Text] [Related]
15. Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.
Miyamoto S; Kato M; Matsuda K; Abiko S; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Shimizu Y; Hatanaka KC; Tsunematsu I; Sakamoto N
Intern Med; 2017; 56(14):1825-1829. PubMed ID: 28717077
[TBL] [Abstract][Full Text] [Related]
16. Acid-suppressing therapies and subsite-specific risk of stomach cancer.
Wennerström ECM; Simonsen J; Camargo MC; Rabkin CS
Br J Cancer; 2017 Apr; 116(9):1234-1238. PubMed ID: 28350791
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitor therapy after
Tan MC; Graham DY
BMJ Evid Based Med; 2018 Jun; 23(3):111-112. PubMed ID: 29599181
[No Abstract] [Full Text] [Related]
18. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy.
Gong EJ; Kim DH; Ahn JY; Na HK; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Park Y; Kim MJ
Digestion; 2020; 101(3):279-286. PubMed ID: 31067538
[TBL] [Abstract][Full Text] [Related]
19. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.
Wada Y; Ito M; Takata S; Kitamura S; Takamura A; Tatsugami M; Imagawa S; Matsumoto Y; Tanaka S; Yoshihara M; Chayama K
Hepatogastroenterology; 2009; 56(91-92):624-8. PubMed ID: 19621668
[TBL] [Abstract][Full Text] [Related]
20. Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.
Paroni Sterbini F; Palladini A; Masucci L; Cannistraci CV; Pastorino R; Ianiro G; Bugli F; Martini C; Ricciardi W; Gasbarrini A; Sanguinetti M; Cammarota G; Posteraro B
Appl Environ Microbiol; 2016 Nov; 82(22):6633-6644. PubMed ID: 27590821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
